Stefan Evers
Impact in
- Molecular Medicine top 1%
- Antibiotic Resistance in Bacteria
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
Papers in
- Oncology 11
- Cancer Immunotherapy and Biomarkers 8
- Peptidase Inhibition and Analysis 3
-
- Monoclonal and Polyclonal Antibodies Research 7
- Radiopharmaceutical Chemistry and Applications 4
- Co-authors
- Priti S. Hegde (1 shared paper)Vaios Karanikas (1 shared paper)Patrice M. Courvalin (5 shared papers)Sylvie Dutka‐Malen (2 shared papers)Richard Quintiliani (2 shared papers)Hanno Langen (5 shared papers)Béla Takács (3 shared papers)Peter E. Reynolds (2 shared papers)
- Journals
- Annals of Oncology (5 papers)Electrophoresis (4 papers)PROTEOMICS (4 papers)Clinical Cancer Research (2 papers)Gene (2 papers)
- Partner nations
- SwitzerlandFranceNetherlands
In The Last Decade
Stefan Evers
34 papers receiving 2.6k citations
Stefan Evers's Hit Papers
Peers
Comparison fields: 5 of 90
- Molecular Medicine 498
- Oncology 842
- Spectroscopy 311
- Infectious Diseases 297
- Clinical Biochemistry 59
Countries citing papers authored by Stefan Evers
This map shows the geographic impact of Stefan Evers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefan Evers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefan Evers more than expected).
Fields of papers citing papers by Stefan Evers
This network shows the impact of papers produced by Stefan Evers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefan Evers. The network helps show where Stefan Evers may publish in the future.
Co-authors
The 25 scholars most cited alongside Stefan Evers, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The Where, the When, and the How of Immune Monitoring for Cancer Immunotherapies in the Era of Checkpoint Inhibition Hit paper breakdown → | 2016 | 766 |
| 2 | 2017 | 244 | |
| 3 | 1995 | 214 | |
| 4 | 1993 | 140 | |
| 5 | 2000 | 130 | |
| 6 | 2001 | 115 | |
| 7 | 1993 | 103 | |
| 8 | 2021 | 100 | |
| 9 | 1996 | 98 | |
| 10 | 2004 | 95 | |
| 11 | 1994 | 81 | |
| 12 | 2004 | 79 | |
| 13 | 2004 | 70 | |
| 14 | 2010 | 68 | |
| 15 | 2018 | 68 | |
| 16 | 1997 | 66 | |
| 17 | 1998 | 57 | |
| 18 | 2001 | 49 | |
| 19 | 2002 | 42 | |
| 20 | 2018 | 34 |
About Stefan Evers
Stefan Evers is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging, Molecular Medicine, Spectroscopy and Genetics, having authored 35 papers that have together received 2.7k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (8 papers), Monoclonal and Polyclonal Antibodies Research (7 papers), Advanced Proteomics Techniques and Applications (5 papers), Bacterial Genetics and Biotechnology (5 papers), Antibiotic Resistance in Bacteria (5 papers), Radiopharmaceutical Chemistry and Applications (4 papers), Peptidase Inhibition and Analysis (3 papers) and Antimicrobial Resistance in Staphylococcus (2 papers). The work is most often cited by research in Molecular Medicine (498 citations), Oncology (842 citations), Spectroscopy (311 citations), Infectious Diseases (297 citations) and Clinical Biochemistry (59 citations). Stefan Evers has collaborated with scholars based in Switzerland, France and Netherlands. Frequent co-authors include Priti S. Hegde, Vaios Karanikas, Patrice M. Courvalin, Sylvie Dutka‐Malen, Richard Quintiliani, Hanno Langen, Béla Takács, Peter E. Reynolds, Michael Fountoulakis and Peter Berndt. Their work appears in journals such as Annals of Oncology, Electrophoresis, PROTEOMICS, Clinical Cancer Research and Gene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.